Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors

International Immunology

Volumn 15, Issue 8, 2003, Pages 1017-1025

  Iwata, Makoto ^a   Eshima, Yuko ^a   Kagechika, Hiroyuki ^b  

^a MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cytokine; Differentiation; Nuclear receptor; T lymphocyte; Vitamin

Indexed keywords

4 (7,8,9,10 TETRAHYDRO 5,7,7,10,10 PENTAMETHYL 5H BENZO[E]NAPHTHO[2,3 B][1,4]DIAZEPIN 13 YL)BENZOIC ACID; 4 [2,3 (2,5 DIMETHYL 2,5 HEXANO) 5 METHYL 5H DIBENZO[B,E][1,4]DIAZEPIN 11 YL]BENZOIC ACID; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 3; INTERLEUKIN 4; IONOMYCIN; LE 540; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEUKOTRIENE RECEPTOR STIMULATING AGENT; PA 452; PHORBOL 13 ACETATE 12 MYRISTATE; RECEPTOR BLOCKING AGENT; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR STIMULATING AGENT; RETINOIC X RECEPTOR BLOCKING AGENT; RETINOIC X RECEPTOR STIMULATING AGENT; RETINOID X RECEPTOR; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR; TAMIBAROTENE; TP 80; TZ 335; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES; ANTIGENS, CD28; ANTIGENS, CD3; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MAF; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RECEPTORS, INTERLEUKIN-4; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRETINOIN; VITAMIN A;

EID: 0041522463     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg101     Document Type: Review

References (46)

1. h2 function. J. Immunol. 152:1515.
2. Racke, M. K., Burnett, D., Pak, S., Albert, P. S., Cannella, B., Raine, C. S., McFarlin, D. E. and Scott, D. E. 1995. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J. Immunol. 154:450.
3. Cui, D., Moldoveanu, Z. and Stephensen, C. B. 2000. High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice. J. Nutr. 130:1132.
4. Hoyos, B., Imam, A., Chua, R., Swenson, C., Tong, G., Levi, E., Noy, N. and Hämmerling, U. 2000. The cysteine-rich regions of the regulatory domains of Raf and protein kinase C as retinoid receptors. J. Exp. Med. 192:835.
5. Tickle, C. and Eichele, G. 1994. Vertebrate limb development. Annu. Rev. Cell. Biol. 10:121.
6. Collins, S. J. 2002. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 16:1896.
7. Iwata, M., Mukai, M., Nakai, Y. and Iseki, R. 1992. Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. J. Immunol. 149:3302.
8. Mangelsdorf, D. J. and Evans, R. M. 1995. The RXR heterodimers and orphan receptors. Cell 83:841.
9. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:940.
10. + T cells. Br. J. Pharmacol. 130:581.
11. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
12. Hoag, K. A., Nashold, F. E., Goverman, J. and Hayes, C. E. 2002. Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-presenting cells. J. Nutr. 132:3736.
13. h2 development via retinoid X receptor pathway. J. Immunol. 168:4495.
14. + T lymphocytes. J. Immunol. 162:766.
15. Gudmundsdottir, H., Wells, A. D. and Turka, L. A. 1999. Dynamics and requirements of T cell clonal expansion in vivo at the signal-cell level: effector function is linked to proliferative capacity. J. Immunol. 162:5212.
16. Rogers, P. R., Dubey, C. and Swain, S. L. 2000. Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J. Immunol. 164:2338.
17. Grusby, M. J., Auchincloss, H., Jr, Lee, R., Johnson, R. S., Spencer, J. P., Zijlstra, M., Jaenisch, R., Papaioannou, V. E. and Glimcher, L. H. 1993. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl Acad. Sci. USA 90:3913.
18. h1 development by progesterone and glucocorticoids. J. Immunol 168:1087.
19. + thymocytes to the CD4 lineage without TCR engagement. Int. Immunol. 8:297.
20. + thymocytes in suspension culture. Eur. J. Immunol. 26:2081.
21. Leo, O., Foo, M., Sachs, D. H., Samelson, L. E. and Bluestone, J. A. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl Acad. Sci. USA 84:1374.
22. Adachi, S., Amasaki, Y., Miyatake, S., Arai, N. and Iwata, M. 2000. Successive expression and activation of NFAT family members during thymocyte differentiation. J. Biol. Chem. 275:14708.
23. McPhillips, D. M., Kalin, J. R. and Hill, D. H. 1987. The pharmacokinetics of all-trans-retinoic acid and N-(2-hydroxyethyl)retinamide in mice as determined with a sensitive and convenient procedure. Solid-phase extraction and reverse-phase high performance liquid chromatography. Drug Metab. Dispos. 15:207.
24. h1 lineage commitment. Cell 100:655.
25. h2 cells. J. Exp. Med. 185:817.
26. Ho, I.-C., Hodge, M. R., Rooney, J. W. and Glimcher, L. H. 1996. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85:973.
27. Mosley, B., Beckmann, P. M., March, C. J., Idzerda, R. L., Gimpel, S. D., VandenBos, T., Friend, D., Alpert, A., Anderson, D. and Jackson, J. 1989. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335.
28. h2 cytokine gene expression in CD4 T cells. Cell 89:587.
29. Urbach, J. and Rando, R. R. 1994. Isomerization of all-transretinoic acid to 9-cis-retinoic acid. Biochem. J. 299:459.
30. Umemiya, H., Fukasawa, H., Ebisawa, M., Eyrolles, L., Kawachi, E., Eisenmann, G., Gronemeyer, H., Hashimoto, Y., Shudo, K. and Kagechika, H. 1997. Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. J. Med. Chem. 40:4222.
31. Takahashi, B., Ohta, K., Kawachi, E., Fukasawa, H., Hashimoto, Y. and Kagechika, H. 2002. Novel retinoid X receptor antagonists: specific inhibition of retinoid synersism in RXR-RAR heterodimer actions. J. Med. Chem. 45:3327.
32. Kagechika, H., Kawachi, E., Hashimoto, Y., Himi, T. and Shudo, K. 1988. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J. Med. Chem. 31:2182.
33. Ebisawa, M., Ohta, K., Kawachi, E., Fukasawa, H., Hashimoto, Y. and Kagechika, H. 2001. Novel retinoidal tropolone derivatives. Bioisosteric relationship of tropolone ring with benzoic acid moiety in retinoid structure. Chem. Pharm. Bull. 49:501.
34. Ebisawa, M., Kawachi, E., Fukasawa, H., Hashimoto, Y., Itai, A., Shudo, K. and Kagechika, H. 1998. Novel thiazolidinedione derivatives with retinoid synergistic activity. Biol. Pharm. Bull. 21:547.
35. Ohta, K., Kawachi, E., Inoue, N., Fukasawa, H., Hashimoto, Y., Itai, A. and Kagechilka, H. 2000. Retinoidal pyrimidinecarboxylic acids. Unexpected diaza-substituent effects in retinobenzoic acids. Chem. Pham. Bull. 48:1504.
36. h1 lymphocytes depends on the CD28 costimulatory pathway. J. Immunol. 156:2674.
37. Barnett, J. B. 1982. Immunomodulating effects of 13-cis-retinoic acid on the IgE response of BALB/c mice. Int. Arch. Allergy Immunol. 69:368.
38. Schüle, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone, L. J., Bolado, J., Verma, I. M. and Evans, R. M. 1991. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl Acad. Sci. USA 88:6092.
39. Na, S.-Y., Kang, B. Y., Chung, S. W., Han, S.-J., Ma, X., Trinchieri, G., Im, S.-Y., Lee, J. W. and Kim, T. S. 1999. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFκB. J. Biol. Chem. 274:7674.
40. 3 in NRP-152 rat prostatic epithelial cells. J. Cell Physiol. 166:231.
41. h cells. J. Immunol. 161:1664.
42. Gorelik, L., Constant, S. and Flavell, R. A. 2002. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195:1499.
43. h type 2 development through inhibition of GATA-3 expression. J. Immunol. 165:4773.
44. h2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur. J. Immunol. 30:21597.
45. Sommer, A. 1993. Vitamin A, infectious disease, and childhood mortality: a 2 cent solution? J. Infect. Dis. 167:1003.
46. Degitz, S. J., Kosian, P. A., Makynen, E. A., Jensen, K. M. and Ankley, G. T. 2000. Stage- and species-specific developmental toxicity of all-trans retinoic acid in four native North American ranids and Xenopus laevis. Toxicol. Sci. 57:264.